The Gross Margin of Astrazeneca Pharma India Ltd (ASTRAZEN.NS) is 47.66%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2024-03-31 | 47.66% |
2023-03-31 | 57.05% |
2022-03-31 | 54.62% |
2021-03-31 | 58.47% |
2020-03-31 | 58.87% |
2019-03-31 | 61.84% |
2018-03-31 | 59.29% |
2017-03-31 | 60.86% |
2016-03-31 | 60.51% |
2015-03-31 | 57.84% |